Skip to main content
. 2020 Mar 1;27(3):226–244. doi: 10.5551/jat.49536

Supplementary Table 4. Association analyses of ACTB with hypertension in the case-control study.

SNP Group WT/HT/MT OR (95% CI)a
Allele gene
Additive model Dominant model Recessive model Major/minor OR (95% CI)/Pb Pc
rs852426 TT/TC/CC T/C
Case 1217/696/99 1.036 (0.929–1.156) 1.006 (0.884–1.144) 1.282 (0.944–1.740) 3130/894 0.963 (0.869–1.068) 0.478
Control 1342/776/88 P = 0.521 P = 0.930 P = 0.112 3460/952 P = 0.239
rs852423 AA/AG/GG A/G
Case 993/809/209 1.040 (0.946–1.144) 1.049 (0.925–1.190) 1.063 (0.863–1.309) 2795/1227 0.961 (0.874–1.056) 0.406
Control 1119/869/221 P = 0.413 P = 0.457 P = 0.568 3107/1311 P = 0.235
rs2966449 TT/TC/CC T/C
Case 1135/763/114 0.973 (0.877–1.080) 0.975 (0.858–1.107) 0.933 (0.713–1.220) 3033/991 1.005 (0.910–1.110) 0.924
Control 1250/823/134 P = 0.606 P = 0.696 P = 0.612 3323/1091 P = 0.462

WT, wild type, HT, heterozygote, MT, mutant type.

a

Adjusted for age, gender, body mass index (BMI), glucose (GLU), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), smoking and drinking status.

b

P value of χ2 test for comparison of allele frequencies between hypertension case and control groups.

c

P value of χ2 test for comparison of genotype between hypertension case and control groups.

The unsuccessful genotyped number of rs852426, rs852423 and rs2966449 was 4, 2 and 3, respectively.